Navigation Links
New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF
Date:6/30/2009

on in patients undergoing infertility management, it is believed that it will have a major implication on the decision-making process when choosing the appropriate gonadotropin for ovarian stimulation.[1]

"I think the cost-effectiveness of treatments is a real issue for couples considering infertility treatment such as IVF today", says Clare Lewis-Jones from Infertility Network UK. "Despite the economic downturn, we see that couples will somehow find the money for treatment, although many have to make sacrifices in order to do this - it's a question of priorities and the opportunity of having a family is an extremely high priority for infertile couples."

MENOPUR

MENOPUR belongs to a class of drugs known as gonadotropins and contains both FSH (follicle stimulating hormone) and hCG-driven (human chorionic gonadotropin) LH-activity (luteinizing hormone). HP-hMG is used to stimulate the development of multiple follicles in women participating in an ART programme. HP-hMG is also used to treat infertility in women caused by anovulation (low-level production of eggs). MENOPUR is used by over 75,000 patients each year and is currently licensed in over 50 countries across the world

About Ferring Pharmaceuticals

Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of reproductive health, urology, gastroenterology and endocrinology. Ferring's fertility portfolio of treatments gives infertile couples the chance to have babies and includes its flagship brand MENOPUR (HP-hMG), a recognised high quality treatment for infertility. Ferring has operating subsidiaries in over 45 countries. To learn more about Ferring or our products please visit http://www.ferring.com.

References:

1. Wex
'/>"/>

SOURCE Ferring Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
2. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
4. Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Osteoarthritis
5. New Data from the Framingham Heart Study Supports PAT Technology to Diagnose Early Cardiovascular Disease
6. Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood
7. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
8. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
9. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
10. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
11. New Clinical Data Further Supports Chromium Picolinates Role in Enhancing Brain Activity in Older Adults

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)..., CHICAGO, Nov. 29 At the 95th S...logical Society of North America (RSNA), "Images, ...hcare booth (#825) from November 29 to December 3 ...side Center, Hall D) in Chicago. This year,s booth...f Siemens support for its customers to generate, p...
(Date:11/29/2009)..., CHICAGO, Nov. 29 FUJIFILM Medi...eld Digital Mammography (FFDM) with over 7,000 ins...M system for the first time in the US. The Aspire...ous selenium (a-Se) next generation detector techn... noise and higher spatial resolution at a reduced ...
(Date:11/28/2009)..., CHICAGO, Nov. 28 Siemens Healt... of its Tim ® (Total imaging matrix) technol...ghput) engine. Both technologies are introduced in...the new MAGNETOM Skyra* 3T scanners at the 95th Sc...ogical Society of North America (RSNA) from Novemb...
Breaking Medicine Technology:Siemens Delivers Images per the Customer's Request - 'Images My Way' 2Siemens Delivers Images per the Customer's Request - 'Images My Way' 3Siemens Delivers Images per the Customer's Request - 'Images My Way' 4Siemens Delivers Images per the Customer's Request - 'Images My Way' 5Siemens Delivers Images per the Customer's Request - 'Images My Way' 6Siemens Delivers Images per the Customer's Request - 'Images My Way' 7Siemens Delivers Images per the Customer's Request - 'Images My Way' 8Siemens Delivers Images per the Customer's Request - 'Images My Way' 9FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 2FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 3FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 4Siemens Introduces Its New Power Couple at RSNA 2009 2Siemens Introduces Its New Power Couple at RSNA 2009 3Siemens Introduces Its New Power Couple at RSNA 2009 4Siemens Introduces Its New Power Couple at RSNA 2009 5Siemens Introduces Its New Power Couple at RSNA 2009 6Siemens Introduces Its New Power Couple at RSNA 2009 74 out of 5 CA Voters Demand Health Insurer 22Code of Conduct 22 50690 14 out of 5 CA Voters Demand Health Insurer 22Code of Conduct 22 50690 24 out of 5 CA Voters Demand Health Insurer 22Code of Conduct 22 50690 34 out of 5 CA Voters Demand Health Insurer 22Code of Conduct 22 50690 44 out of 5 CA Voters Demand Health Insurer 22Code of Conduct 22 50690 54 out of 5 CA Voters Demand Health Insurer 22Code of Conduct 22 50690 6Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of Abortion Pill 50687 1Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of Abortion Pill 50687 2Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported 50684 1Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported 50684 2Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported 50684 3
...tCall/ --,Medivation, Inc. today announced that it...ime on Monday, June 11, to discuss top-line,12-mon...ebo-controlled Phase 2 clinical trial of Dimebon(T...ease. , Rachelle Doody, M.D., Ph.D., lead investig...lts for the first time at a,scientific meeting at ...
...al results from a,Phase II study presented for the... annual meeting showed that MK-0974, an,investigat...receptor antagonist, significantly improved migrai...placebo, and the relief was,sustained through 24 h...study. Responses specific to other measures, such ...
Other Medicine Technology:Medivation to Host Conference Call to Discuss Top-Line 12-Month,Results From Dimebon Alzheimer's Disease Study 2Medivation to Host Conference Call to Discuss Top-Line 12-Month,Results From Dimebon Alzheimer's Disease Study 3Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 2Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 3Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 4Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 5
(Date:11/28/2009)...nsider change after 30-minute psychosocial interve...HealthDay News) -- A program that gets persistent ...ir dangerous behavior may lead to significant and ... The new study included 184 men and women with two...ere randomly assigned to one of two interventions....
(Date:11/27/2009)...Replikins Ltd. today issued its latest biochemical...s that the lethality of the virus has dropped from...rent outbreak in the spring of 2009 to resting non...H1N1 infectivity count, however, remains increased...er 27, 2009 -- Biotech firm Replikins Ltd., which ...
(Date:11/27/2009)... 27 Shamir Optical Indus...provider of innovative products and technology to ...ts board of directors had declared a dividend dist...(approximately NIS 37.62 million based on the Nove... approximately US$ 0.609 (approximately NIS 2.3 ba...
(Date:11/27/2009)...™ announced today that Spectrum Health (Gran...erprise orthopedic templating solution and its Tra... (PRWEB) November 27, 2009 -- Voyant Heal...and Rapids, Michigan) has licensed its TraumaCad E...raumaCad Extend workflow solution, to allow its or...
(Date:11/26/2009)... The diabetes population in the Uni...rs and annual medical spending on the disease is p... today, according to a study published in the Dece...ging Diabetes ® Program (NCDP), a program of ...from the University of Chicago. ,, According to...
Breaking Medicine News(10 mins):Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4
...ng to the parliament's Health Select Committee the...England needs to be reviewed//. It pointed out...entistry and eye care do not have any comprehensib...t on the patients and the evidence for this fact i...
...eturning from malaria-prone Garo Hills region, Meg...alised with symptoms of the same disease. // ...ay, was admitted to the civil hospital here with m...ict town Tura. Malaria had claimed 40 lives i...
...o Kills/Smoking Kills" -- such health warnings wou...ng which the sellers would attract stringent penal...arnings that could appear on tobacco packages incl...ry headed by Anbumani Ramadoss, who has been a sta...
...ot uncommon to have testimonies of surgeries - ins... patients' bodies, a stark reminder of medical// n...s and even death of unfortunate patients. Statisti...named as the 'magic wand' which will ensure surgeo...
...ot healthy to lose weight soon after giving birth,... being advised about the pitfalls of following cel...gure soon after child birth, which can have seriou...trition levels in both the mother and the baby. A ...
...ury University researcher Dr Victoria Metcalf is o...rs about fish. Metcalf will use the genetic filter...bolize fat. This study will aid in the understandi...ans who get the energy from carbohydrates. In her ...
Other Medicine News:
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: